Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Volcanic Eruptions | 3 | 2019 | 3 | 1.370 |
Why?
|
| Respiratory Tract Diseases | 2 | 2018 | 23 | 1.180 |
Why?
|
| Air Pollutants | 2 | 2018 | 94 | 1.100 |
Why?
|
| Asthma | 8 | 2017 | 380 | 1.080 |
Why?
|
| Allergens | 3 | 2014 | 63 | 0.790 |
Why?
|
| Sulfuric Acids | 2 | 2019 | 4 | 0.730 |
Why?
|
| Sulfur Dioxide | 2 | 2019 | 6 | 0.730 |
Why?
|
| Smog | 1 | 2019 | 1 | 0.680 |
Why?
|
| Hawaii | 12 | 2019 | 1929 | 0.670 |
Why?
|
| Respiration Disorders | 1 | 2018 | 7 | 0.660 |
Why?
|
| Safety Management | 1 | 2018 | 18 | 0.640 |
Why?
|
| Respiratory Hypersensitivity | 2 | 2014 | 16 | 0.570 |
Why?
|
| Environmental Exposure | 1 | 2018 | 216 | 0.550 |
Why?
|
| Particulate Matter | 1 | 2016 | 51 | 0.530 |
Why?
|
| Hypertension | 1 | 2019 | 796 | 0.400 |
Why?
|
| Immunoglobulin E | 4 | 2016 | 55 | 0.330 |
Why?
|
| Th2 Cells | 2 | 2007 | 58 | 0.320 |
Why?
|
| Pregnancy Complications | 1 | 2010 | 126 | 0.320 |
Why?
|
| Smoking | 2 | 2017 | 940 | 0.310 |
Why?
|
| Caveolin 1 | 1 | 2007 | 29 | 0.310 |
Why?
|
| Young Adult | 6 | 2021 | 4268 | 0.300 |
Why?
|
| Prevalence | 3 | 2018 | 1455 | 0.300 |
Why?
|
| Air Pollution | 2 | 2019 | 60 | 0.290 |
Why?
|
| Transforming Growth Factor beta | 1 | 2007 | 197 | 0.270 |
Why?
|
| Humans | 18 | 2023 | 37093 | 0.270 |
Why?
|
| Down-Regulation | 1 | 2007 | 435 | 0.260 |
Why?
|
| Health Behavior | 1 | 2010 | 537 | 0.260 |
Why?
|
| Adolescent | 5 | 2021 | 5363 | 0.250 |
Why?
|
| Cardiac Myosins | 2 | 2016 | 8 | 0.240 |
Why?
|
| Receptors, Interleukin-4 | 1 | 2003 | 10 | 0.240 |
Why?
|
| Hypersensitivity | 1 | 2003 | 30 | 0.230 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 2721 | 0.220 |
Why?
|
| Substance-Related Disorders | 1 | 2010 | 730 | 0.210 |
Why?
|
| Female | 11 | 2023 | 20969 | 0.190 |
Why?
|
| Laboratories | 1 | 2021 | 35 | 0.190 |
Why?
|
| Male | 10 | 2023 | 20025 | 0.170 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2003 | 767 | 0.170 |
Why?
|
| Schools | 2 | 2017 | 260 | 0.150 |
Why?
|
| Students | 2 | 2023 | 519 | 0.140 |
Why?
|
| Smoking Cessation | 2 | 2018 | 517 | 0.140 |
Why?
|
| Rheumatic Fever | 1 | 2016 | 13 | 0.140 |
Why?
|
| Chlamydophila pneumoniae | 1 | 2016 | 8 | 0.140 |
Why?
|
| Aged | 3 | 2018 | 6741 | 0.140 |
Why?
|
| Wind | 1 | 2016 | 10 | 0.140 |
Why?
|
| Catechin | 1 | 2016 | 31 | 0.140 |
Why?
|
| Adult | 4 | 2018 | 11712 | 0.140 |
Why?
|
| Forced Expiratory Volume | 1 | 2016 | 70 | 0.130 |
Why?
|
| Schools, Medical | 1 | 2018 | 198 | 0.130 |
Why?
|
| Curriculum | 1 | 2018 | 265 | 0.130 |
Why?
|
| Autoantibodies | 1 | 2016 | 103 | 0.130 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 2379 | 0.130 |
Why?
|
| Risk Assessment | 1 | 2018 | 753 | 0.130 |
Why?
|
| Streptococcus pyogenes | 2 | 2016 | 27 | 0.130 |
Why?
|
| Environmental Monitoring | 1 | 2016 | 192 | 0.120 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2016 | 234 | 0.120 |
Why?
|
| Hepatitis B Antibodies | 1 | 2013 | 6 | 0.120 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2013 | 11 | 0.120 |
Why?
|
| Hepatitis B virus | 1 | 2013 | 13 | 0.120 |
Why?
|
| Middle Aged | 3 | 2018 | 10129 | 0.120 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 149 | 0.120 |
Why?
|
| Disease Progression | 1 | 2016 | 601 | 0.120 |
Why?
|
| Risk Factors | 2 | 2018 | 3562 | 0.110 |
Why?
|
| Heart Failure | 1 | 2016 | 235 | 0.110 |
Why?
|
| Antioxidants | 1 | 2016 | 416 | 0.110 |
Why?
|
| Child | 3 | 2016 | 3131 | 0.110 |
Why?
|
| Healthcare Disparities | 1 | 2016 | 494 | 0.100 |
Why?
|
| Rheumatic Heart Disease | 1 | 2010 | 5 | 0.090 |
Why?
|
| Obstetric Labor, Premature | 1 | 2010 | 13 | 0.090 |
Why?
|
| Odds Ratio | 1 | 2010 | 534 | 0.080 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2007 | 6 | 0.080 |
Why?
|
| Interleukins | 1 | 2007 | 29 | 0.080 |
Why?
|
| Pulmonary Fibrosis | 1 | 2007 | 31 | 0.080 |
Why?
|
| Lymphocyte Subsets | 1 | 2007 | 21 | 0.080 |
Why?
|
| Selenoprotein P | 1 | 2007 | 50 | 0.070 |
Why?
|
| Flow Cytometry | 1 | 2007 | 399 | 0.070 |
Why?
|
| Selenium | 1 | 2007 | 148 | 0.060 |
Why?
|
| General Surgery | 1 | 2005 | 19 | 0.060 |
Why?
|
| Education, Medical, Continuing | 1 | 2005 | 32 | 0.060 |
Why?
|
| Mice, Knockout | 1 | 2007 | 933 | 0.060 |
Why?
|
| Physician's Role | 1 | 2005 | 38 | 0.060 |
Why?
|
| Pregnancy | 1 | 2010 | 1549 | 0.060 |
Why?
|
| Lung | 1 | 2007 | 446 | 0.060 |
Why?
|
| Eosinophils | 1 | 2003 | 20 | 0.060 |
Why?
|
| Hong Kong | 1 | 2023 | 27 | 0.060 |
Why?
|
| Counseling | 1 | 2005 | 116 | 0.060 |
Why?
|
| Family Health | 1 | 2003 | 56 | 0.060 |
Why?
|
| Interprofessional Relations | 1 | 2023 | 54 | 0.060 |
Why?
|
| Epitopes | 2 | 2016 | 148 | 0.060 |
Why?
|
| Protein Subunits | 1 | 2003 | 87 | 0.060 |
Why?
|
| Internship and Residency | 1 | 2005 | 125 | 0.060 |
Why?
|
| Gene Frequency | 1 | 2003 | 195 | 0.060 |
Why?
|
| Time Factors | 1 | 2007 | 1742 | 0.050 |
Why?
|
| Mice | 3 | 2007 | 5913 | 0.050 |
Why?
|
| Obesity | 1 | 2010 | 1067 | 0.050 |
Why?
|
| Genotype | 1 | 2003 | 730 | 0.050 |
Why?
|
| Immunoglobulin G | 2 | 2013 | 237 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2007 | 1908 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2013 | 1418 | 0.040 |
Why?
|
| Ovalbumin | 2 | 2007 | 47 | 0.040 |
Why?
|
| Animals | 3 | 2007 | 15081 | 0.040 |
Why?
|
| Anxiety | 1 | 2023 | 754 | 0.040 |
Why?
|
| Education, Medical | 1 | 2018 | 104 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 448 | 0.030 |
Why?
|
| Adolescent Behavior | 1 | 2017 | 253 | 0.030 |
Why?
|
| Hepatitis B Vaccines | 1 | 2013 | 14 | 0.030 |
Why?
|
| Comorbidity | 1 | 2016 | 623 | 0.030 |
Why?
|
| Seroepidemiologic Studies | 1 | 2013 | 68 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2016 | 661 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2007 | 1207 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2016 | 1492 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2016 | 1518 | 0.030 |
Why?
|
| Epitope Mapping | 1 | 2010 | 31 | 0.020 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2007 | 18 | 0.020 |
Why?
|
| STAT6 Transcription Factor | 1 | 2007 | 16 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2007 | 56 | 0.020 |
Why?
|
| Glutathione Peroxidase | 1 | 2007 | 111 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 623 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2007 | 661 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2007 | 259 | 0.020 |
Why?
|
| Role Playing | 1 | 2005 | 2 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2007 | 928 | 0.020 |
Why?
|
| Cytokines | 1 | 2007 | 602 | 0.010 |
Why?
|
| Inflammation | 1 | 2007 | 618 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2007 | 1609 | 0.010 |
Why?
|
| Physician-Patient Relations | 1 | 2002 | 128 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2002 | 123 | 0.010 |
Why?
|
| Diet | 1 | 2007 | 801 | 0.010 |
Why?
|
| Community Health Services | 1 | 2002 | 185 | 0.010 |
Why?
|
| Telemedicine | 1 | 2002 | 182 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2002 | 1369 | 0.010 |
Why?
|